Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243802 · ClinicalTrials.gov registry record
Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 23
- Enrollment target
NCT00243802 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 23 participants.
The verdict
NCT00243802 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of the study is to look at the differences between people who have irregular heart beats coming from the upper chamber of the heart (atrial fibrillation) compared to those who do not have these irregular beats.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243802
The ClinicalTrials.gov registry entry for NCT00243802 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00243802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243802 about?
NCT00243802 is a clinical study titled "Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation". The purpose of the study is to look at the differences between people who have irregular heart beats coming from the upper chamber of the heart (atrial fibrillation) compared to those who do not have these irregular beats.
What is the current status of trial NCT00243802?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2005-05. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00243802?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.